Literature DB >> 19349790

Anti-VEGF therapy in proliferative diabetic retinopathy.

Walid Abdallah1, Amani A Fawzi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349790     DOI: 10.1097/IIO.0b013e31819fd84a

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  13 in total

1.  Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.

Authors:  Yan Lu; Nan Zhou; Xiao Huang; Jin-Wei Cheng; Feng-Qian Li; Rui-Li Wei; Ji-Ping Cai
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 2.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

Review 3.  AGEs, RAGE, and diabetic retinopathy.

Authors:  Hongliang Zong; Micheal Ward; Alan W Stitt
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 4.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

5.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08

6.  Differential regulation of angiogenesis using degradable VEGF-binding microspheres.

Authors:  David G Belair; Michael J Miller; Shoujian Wang; Soesiawati R Darjatmoko; Bernard Y K Binder; Nader Sheibani; William L Murphy
Journal:  Biomaterials       Date:  2016-03-16       Impact factor: 12.479

7.  Current concepts in intravitreal drug therapy for diabetic retinopathy.

Authors:  Anant Pai; Maha M El Shafei; Osman A Z Mohammed; Mustafa Al Hashimi
Journal:  Saudi J Ophthalmol       Date:  2010-06-30

Review 8.  ERK5 Mediated Signalling in Diabetic Retinopathy.

Authors:  Yuexiu Wu; Subrata Chakrabarti
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2015

9.  Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.

Authors:  Jian Sun; Wei Huang; Shuo-Fei Yang; Xiao-Pei Zhang; Qing Yu; Zhi-Qing Zhang; Jin Yao; Ke-Ran Li; Qin Jiang; Cong Cao
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

Review 10.  The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.

Authors:  Gemma Tremolada; Claudia Del Turco; Rosangela Lattanzio; Silvia Maestroni; Anna Maestroni; Francesco Bandello; Gianpaolo Zerbini
Journal:  Exp Diabetes Res       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.